Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
申请人:Chappell Mark Donald
公开号:US20080125468A1
公开(公告)日:2008-05-29
The present invention discloses novel compounds of Formula (I), or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.
GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES
申请人:ELI LILLY AND COMPANY
公开号:EP1758859B1
公开(公告)日:2013-07-17
US7989457B2
申请人:——
公开号:US7989457B2
公开(公告)日:2011-08-02
Suzuki-Miyaura cross-coupling catalyzed by protein-stabilized palladium nanoparticles under aerobic conditions in water: application to a one-pot chemoenzymatic enantioselective synthesis of chiral biaryl alcohols
protein (DNA binding protein from starved cells) and the use of this precatalyst system in Suzuki-Miyauracross-couplingreactions under aerobic conditions in water is described, as well as a two-step one-potSuzuki-Miyauracross-coupling followed by an enantioselective enzyme-catalyzed reduction to form chiral biaryl alcohols.